Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Yamanouchi scientists design series of anticoagulants

July 19, 2002

Pharmion acquires U.S. marketing rights to Innohep

July 19, 2002

GTC Biotherapeutics completes rhATIII study

July 17, 2002

Serine protease inhibitors with anticoagulant activity described by Pharmacia

July 16, 2002

Novel factor Xa inhibitor and oral prodrug presented at IUPHAR 2002 by Kissei

July 15, 2002

Antiplatelet/antithrombotic efficacy demonstrated for P2Y12 receptor antagonists

July 15, 2002

BMS claims serine protease inhibitors with anticoagulant activity

July 12, 2002

New class of P2Y12 antagonists designed at Inspire as antithrombotics

July 12, 2002

SSR-182289: novel oral thrombin inhibitor with high potency and selectivity

July 10, 2002

Effective and safe new antithrombotic presented by Pfizer at IUPHAR 2002

July 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...